Evidence map›Paper›PMID 30425759›Full record

ArticleJournal of clinical medicine research2018

Present Status and Perspectives on Future Roles of Japanese Clinical Research Coordinators.

Hiroaki Yanagawa, Hiroshi Nokihara, Hideto Yokoi, Hitoshi Houchi, Masahiro Nagai, Risako Yamashita, Narufumi Suganuma, Masamitsu Hyodo, Shikoku Collaborative Group for Promotion of Clinical Trials

Abstract read
In one paragraph

Article in Journal of clinical medicine research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroaki YanagawaClinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
Hiroshi NokiharaClinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
Hideto YokoiClinical Research Support Center, Kagawa University Hospital, Kagawa, Japan.
Hitoshi HouchiClinical Research Support Center, Kagawa University Hospital, Kagawa, Japan.
Masahiro NagaiClinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan.
Risako YamashitaClinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan.
Narufumi SuganumaIntegrated Center for Advanced Medical Technologies, Kochi Medical School Hospital, Kochi, Japan.
Masamitsu HyodoIntegrated Center for Advanced Medical Technologies, Kochi Medical School Hospital, Kochi, Japan.
Shikoku Collaborative Group for Promotion of Clinical Trials

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe new Clinical Trials Act that recently came into effect in Japan emphasizes the reliability of investigator-initiated clinical trials. Although Japanese clinical research coordinators have been mainly engaged in operational roles in industry-initiated clinical trials for drug approval (registration trials), broadening their contribution to cover more types of clinical research may lead to quality improvement of clinical research. To ultimately establish a clinical research infrastructure that meets the needs of the new era of Clinical Trials Act, here we gathered basic information on how clinical research coordinators might make such contributions.

methodsWe conducted a survey using self-reporting questionnaires in clinical research-related personnel to examine present status and the perspectives toward broader contribution of clinical research coordinators. The study participants were attendee of group discussion of a clinical research-related meeting in Shikoku area of Japan held in August 2017.

resultsAmong 88 participants, 69 responded (response rate: 78.4%) and 68 respondents (98.6%) were engaged in support and management of clinical research. The main area of involvement was industry-initiated registration trials (48, 69.7%), and main roles of involvement were cooperators who plays roles under the guidance of investigators (41, 59.5%). When divided by occupation into clinical research coordinators (n = 41) and other clinical research-related personnel (n = 28), approximately half of the respondents in each group replied positively to wanting broader involvement of clinical research coordinators as a clinical research professional.

conclusionThe present study revealed that about half of the clinical research coordinators and other clinical research-related personnel view a broadening of involvement of clinical research coordinators in research activities positively. Accordingly, a structured practical program aimed at encouraging such involvement may help to expand and strengthen their contribution into the future. Whether greater involvement of clinical research coordinators in clinical research will help to ensure the reliability of investigator-initiated clinical research warrants further study.

Indexed as

Clinical researchClinical research coordinatorsClinical Trials ActJapanPerspectiveQuality assuranceRole

Identifiers

PMID30425759
PMCPMC6225862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.